Oppenheimer maintains AGI at Outperform, lowers price target to $8 from $9
Oppenheimer kept AGI's rating at Outperform but reduced its price target to $8 from $9, an 11.1% cut. The new target suggests a 48.4% upside from the Nov 11 closing price of $5.39.




